Advances in Next-generation sequencing (NGS) are improving approaches to develop rapid, accurate, detection, treatment, and routine monitoring of cancer. The use of NGS for developing new solutions for applications such as the detection and monitoring of minimal residual disease (MRD), methylation or exome profiling for clinical oncology research and liquid biopsy-based approaches.

Twist's DNA-based tools are enabling researchers across a variety of scientific disciplines to achieve groundbreaking discoveries.

Twist continues to drive biological innovations aimed at making the world safer, healthier and more sustainable.

A Safe and Effective Alternative to “Live Virus”

Controls based on viral nucleic acids extracted from either an infected patient or from live virus propagated in cell culture have safety and security concerns. Synthetic controls created through gene synthesis broaden access across diverse strains while mitigating risk.

Flexible formats for your applications

Choose from Standard, Assay Ready, or Encapsuled Control formulations. The standard format provides the controls at high concentration in a frozen liquid formulation. The Assay Ready Controls are provided as a dried pellet that increases stability. Just as protein encapsulation of viruses offers more stable molecular storage, Twist’s The Encapsulated Control products leverage a metal capsule sealed around a desiccated pellet to enhance stability of the RNA controls.

Both the Assay Ready and the Encapsulated formulations are single use controls. The Assay Ready format allows for shipping at ambient temperatures and storage in standard freezers. The enhanced stability of the Encapsulated controls enables extended shelf life and both ship and store at room temperature. Ambient shipping reduces cost and increases accessibility for researchers across the globe.